Fulcrum Therapeutics, Inc.
FULC • NASDAQ
Fulcrum Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alexander C. Sapir, with a market cap of $526.8M.
Market Cap$526.8M
Employees89.0
CEOAlexander C. Sapir
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Fulcrum Therapeutics, Inc. FAQ
Common questions about Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026.
Fulcrum Therapeutics, Inc. has approximately 89 employees.